Billionaires Holding MGNX

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 34.2M
    Shares Outstanding

  • 995.59M
    Market Cap

News & Insights

ABOUT

MGNX

MacroGenics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company generates its pipeline of product candidates from its propr...

Introducing The New Elon Musk Strategy

NEWS

iBillionaire Joins Forces With IBM Watson

READ MORE